Novel motif:109: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:07, 9 September 2013
name: | motif109_TCNMTMGC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0016070 | RNA metabolic process | 4.242235e-9 |
GO:0097039 | protein linear polyubiquitination | 5.252779e-9 |
GO:0060676 | ureteric bud formation | 5.981552e-9 |
GO:0090304 | nucleic acid metabolic process | 4.403432e-8 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 1.046645e-7 |
GO:0070170 | regulation of tooth mineralization | 1.373464e-7 |
GO:0031076 | embryonic camera-type eye development | 1.816160e-7 |
GO:0016202 | regulation of striated muscle tissue development | 2.023874e-7 |
GO:0007096 | regulation of exit from mitosis | 4.323888e-7 |
GO:0051252 | regulation of RNA metabolic process | 4.435947e-7 |
GO:0021506 | anterior neuropore closure | 5.721996e-7 |
GO:0090342 | regulation of cell aging | 6.756537e-7 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 8.311244e-7 |
GO:0048706 | embryonic skeletal system development | 1.075336e-6 |
GO:0010467 | gene expression | 1.195512e-6 |
GO:0060173 | limb development | 1.224907e-6 |
GO:0045931 | positive regulation of mitotic cell cycle | 1.230646e-6 |
GO:0048634 | regulation of muscle organ development | 1.245035e-6 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.277742e-6 |
GO:0048704 | embryonic skeletal system morphogenesis | 1.303932e-6 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.351436e-6 |
GO:0032774 | RNA biosynthetic process | 1.559624e-6 |
GO:0046884 | follicle-stimulating hormone secretion | 1.829750e-6 |
GO:0032275 | luteinizing hormone secretion | 1.829750e-6 |
GO:0043921 | modulation by host of viral transcription | 2.001727e-6 |
GO:0051253 | negative regulation of RNA metabolic process | 2.406672e-6 |
GO:0006355 | regulation of transcription, DNA-dependent | 2.436035e-6 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 2.900393e-6 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 3.383004e-6 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 3.458260e-6 |
GO:0006139 | nucleobase-containing compound metabolic process | 3.463122e-6 |
GO:0003409 | optic cup structural organization | 3.750403e-6 |
GO:0021623 | oculomotor nerve formation | 3.750403e-6 |
GO:0003404 | optic vesicle morphogenesis | 3.750403e-6 |
GO:0009059 | macromolecule biosynthetic process | 3.756155e-6 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 4.754839e-6 |
GO:0001657 | ureteric bud development | 4.853739e-6 |
GO:0006351 | transcription, DNA-dependent | 5.462604e-6 |
GO:0046782 | regulation of viral transcription | 5.996394e-6 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 7.467340e-6 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 7.479162e-6 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 7.642547e-6 |
GO:0045843 | negative regulation of striated muscle tissue development | 7.725970e-6 |
GO:0048048 | embryonic eye morphogenesis | 1.034357e-5 |
GO:0048596 | embryonic camera-type eye morphogenesis | 1.151550e-5 |
GO:0060576 | intestinal epithelial cell development | 1.157337e-5 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 1.186293e-5 |
GO:0061302 | smooth muscle cell-matrix adhesion | 1.338922e-5 |
GO:0051702 | interaction with symbiont | 1.446065e-5 |
GO:0043922 | negative regulation by host of viral transcription | 1.474126e-5 |
GO:0006268 | DNA unwinding involved in replication | 1.604729e-5 |
GO:0010468 | regulation of gene expression | 1.959631e-5 |
GO:0016570 | histone modification | 1.994426e-5 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 2.002637e-5 |
GO:0071281 | cellular response to iron ion | 2.053310e-5 |
GO:0008033 | tRNA processing | 2.102112e-5 |
GO:0009081 | branched chain family amino acid metabolic process | 2.293652e-5 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 2.487607e-5 |
GO:0034660 | ncRNA metabolic process | 2.503540e-5 |
GO:0009790 | embryo development | 2.597458e-5 |
GO:0034470 | ncRNA processing | 2.672413e-5 |
GO:0010159 | specification of organ position | 2.765300e-5 |
GO:0032274 | gonadotropin secretion | 2.791932e-5 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 2.854428e-5 |
GO:0071934 | thiamine transmembrane transport | 2.951015e-5 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 2.986442e-5 |
GO:0023035 | CD40 signaling pathway | 3.359944e-5 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 3.601889e-5 |
GO:0009083 | branched chain family amino acid catabolic process | 3.634590e-5 |
GO:0000279 | M phase | 3.772346e-5 |
GO:0072009 | nephron epithelium development | 4.068211e-5 |
GO:0006427 | histidyl-tRNA aminoacylation | 4.086610e-5 |
GO:0070933 | histone H4 deacetylation | 4.449908e-5 |
GO:0048705 | skeletal system morphogenesis | 4.627427e-5 |
GO:0042694 | muscle cell fate specification | 4.884919e-5 |
GO:0021603 | cranial nerve formation | 5.058762e-5 |
GO:0051851 | modification by host of symbiont morphology or physiology | 5.288346e-5 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 5.640926e-5 |
GO:0034983 | peptidyl-lysine deacetylation | 5.706396e-5 |
GO:0016569 | covalent chromatin modification | 5.903776e-5 |
GO:0006534 | cysteine metabolic process | 6.032485e-5 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 6.137055e-5 |
GO:0072087 | renal vesicle development | 6.373982e-5 |
GO:0001838 | embryonic epithelial tube formation | 6.484163e-5 |
GO:0072070 | loop of Henle development | 6.751815e-5 |
GO:0010629 | negative regulation of gene expression | 7.079017e-5 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 7.273973e-5 |
GO:0007174 | epidermal growth factor catabolic process | 7.273973e-5 |
GO:0010070 | zygote asymmetric cell division | 7.290388e-5 |
GO:0042696 | menarche | 7.614660e-5 |
GO:0016331 | morphogenesis of embryonic epithelium | 7.863766e-5 |
GO:0035108 | limb morphogenesis | 8.047020e-5 |
GO:0072283 | metanephric renal vesicle morphogenesis | 8.538747e-5 |
GO:0009792 | embryo development ending in birth or egg hatching | 8.644881e-5 |
GO:0070306 | lens fiber cell differentiation | 8.733840e-5 |
GO:0032543 | mitochondrial translation | 8.770538e-5 |
GO:0042891 | antibiotic transport | 9.250680e-5 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 9.250680e-5 |
GO:0021778 | oligodendrocyte cell fate specification | 9.488329e-5 |
GO:0030326 | embryonic limb morphogenesis | 9.685697e-5 |
GO:0002003 | angiotensin maturation | 1.121990e-4 |
GO:0070172 | positive regulation of tooth mineralization | 1.128074e-4 |
GO:0072073 | kidney epithelium development | 1.129905e-4 |
GO:0072077 | renal vesicle morphogenesis | 1.204768e-4 |
GO:0001656 | metanephros development | 1.265222e-4 |
GO:0031327 | negative regulation of cellular biosynthetic process | 1.290771e-4 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 1.313916e-4 |
GO:0072088 | nephron epithelium morphogenesis | 1.370632e-4 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.447571e-4 |
GO:0043009 | chordate embryonic development | 1.503976e-4 |
GO:0070309 | lens fiber cell morphogenesis | 1.575631e-4 |
GO:0035115 | embryonic forelimb morphogenesis | 1.602852e-4 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 1.732538e-4 |
GO:0018205 | peptidyl-lysine modification | 1.758147e-4 |
GO:0032897 | negative regulation of viral transcription | 1.778349e-4 |
GO:0050434 | positive regulation of viral transcription | 1.856269e-4 |
GO:0007141 | male meiosis I | 1.879238e-4 |
GO:0072175 | epithelial tube formation | 1.916838e-4 |
GO:0001302 | replicative cell aging | 1.942545e-4 |
GO:2000648 | positive regulation of stem cell proliferation | 1.995963e-4 |
GO:0070932 | histone H3 deacetylation | 2.047907e-4 |
GO:0044260 | cellular macromolecule metabolic process | 2.120110e-4 |
GO:0072268 | pattern specification involved in metanephros development | 2.150942e-4 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 2.155447e-4 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.179565e-4 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 2.181222e-4 |
GO:0031860 | telomeric 3' overhang formation | 2.181222e-4 |
GO:0021512 | spinal cord anterior/posterior patterning | 2.181222e-4 |
GO:0000096 | sulfur amino acid metabolic process | 2.198919e-4 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 2.319511e-4 |
GO:0002064 | epithelial cell development | 2.349668e-4 |
GO:0070193 | synaptonemal complex organization | 2.379641e-4 |
GO:0035461 | vitamin transmembrane transport | 2.468206e-4 |
GO:0016598 | protein arginylation | 2.556941e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.570270e-4 |
GO:0007129 | synapsis | 2.643498e-4 |
GO:0048635 | negative regulation of muscle organ development | 2.713182e-4 |
GO:0048103 | somatic stem cell division | 2.774937e-4 |
GO:0021779 | oligodendrocyte cell fate commitment | 2.882282e-4 |
GO:0048598 | embryonic morphogenesis | 2.961355e-4 |
GO:0090183 | regulation of kidney development | 2.996844e-4 |
GO:0060900 | embryonic camera-type eye formation | 3.012744e-4 |
GO:0006399 | tRNA metabolic process | 3.058206e-4 |
GO:0035621 | ER to Golgi ceramide transport | 3.077248e-4 |
GO:0010477 | response to sulfur dioxide | 3.077248e-4 |
GO:0043181 | vacuolar sequestering | 3.077248e-4 |
GO:0000023 | maltose metabolic process | 3.077248e-4 |
GO:0002457 | T cell antigen processing and presentation | 3.077248e-4 |
GO:0005985 | sucrose metabolic process | 3.077248e-4 |
GO:0051488 | activation of anaphase-promoting complex activity | 3.096528e-4 |
GO:2000683 | regulation of cellular response to X-ray | 3.162834e-4 |
GO:0033083 | regulation of immature T cell proliferation | 3.170829e-4 |
GO:0070831 | basement membrane assembly | 3.171393e-4 |
GO:0007379 | segment specification | 3.174023e-4 |
GO:0048332 | mesoderm morphogenesis | 3.251618e-4 |
GO:0090402 | oncogene-induced senescence | 3.272702e-4 |
GO:0031326 | regulation of cellular biosynthetic process | 3.336641e-4 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 3.380159e-4 |
GO:0060993 | kidney morphogenesis | 3.551415e-4 |
GO:0010172 | embryonic body morphogenesis | 3.679437e-4 |
GO:0032049 | cardiolipin biosynthetic process | 3.695009e-4 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 3.748375e-4 |
GO:0003310 | pancreatic A cell differentiation | 3.841666e-4 |
GO:0045762 | positive regulation of adenylate cyclase activity | 3.868235e-4 |
GO:0009451 | RNA modification | 3.881303e-4 |
GO:0007190 | activation of adenylate cyclase activity | 3.891137e-4 |
GO:0031324 | negative regulation of cellular metabolic process | 4.036348e-4 |
GO:0060231 | mesenchymal to epithelial transition | 4.088712e-4 |
GO:0009452 | RNA capping | 4.317065e-4 |
GO:0006284 | base-excision repair | 4.382717e-4 |
GO:0009890 | negative regulation of biosynthetic process | 4.388539e-4 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 4.483696e-4 |
GO:0051365 | cellular response to potassium ion starvation | 4.572137e-4 |
GO:0072028 | nephron morphogenesis | 4.716059e-4 |
GO:0033091 | positive regulation of immature T cell proliferation | 4.757629e-4 |
GO:0031281 | positive regulation of cyclase activity | 5.340072e-4 |
GO:0030514 | negative regulation of BMP signaling pathway | 5.482561e-4 |
GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 5.511276e-4 |
GO:0035136 | forelimb morphogenesis | 5.530298e-4 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 5.556359e-4 |
GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5.571935e-4 |
GO:0046092 | deoxycytidine metabolic process | 5.902796e-4 |
GO:0031468 | nuclear envelope reassembly | 5.902796e-4 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 5.904308e-4 |
GO:0003208 | cardiac ventricle morphogenesis | 6.017535e-4 |
GO:0051171 | regulation of nitrogen compound metabolic process | 6.029826e-4 |
GO:0006413 | translational initiation | 6.264400e-4 |
GO:0000072 | M phase specific microtubule process | 6.452144e-4 |
GO:0010556 | regulation of macromolecule biosynthetic process | 6.536938e-4 |
GO:0002686 | negative regulation of leukocyte migration | 6.604936e-4 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 6.794290e-4 |
GO:0050821 | protein stabilization | 6.915875e-4 |
GO:0072081 | specification of nephron tubule identity | 6.983147e-4 |
GO:0002121 | inter-male aggressive behavior | 7.012326e-4 |
GO:0090003 | regulation of establishment of protein localization in plasma membrane | 7.062178e-4 |
GO:0043923 | positive regulation by host of viral transcription | 7.125458e-4 |
GO:0070192 | chromosome organization involved in meiosis | 7.170746e-4 |
GO:0007127 | meiosis I | 7.239627e-4 |
GO:0006348 | chromatin silencing at telomere | 7.545203e-4 |
GO:0035148 | tube formation | 7.987105e-4 |
GO:0060574 | intestinal epithelial cell maturation | 8.099138e-4 |
GO:0048313 | Golgi inheritance | 8.173063e-4 |
GO:0033147 | negative regulation of estrogen receptor signaling pathway | 8.435827e-4 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 8.583793e-4 |
GO:0035304 | regulation of protein dephosphorylation | 8.628113e-4 |
GO:0061004 | pattern specification involved in kidney development | 8.676464e-4 |
GO:0070544 | histone H3-K36 demethylation | 8.744843e-4 |
GO:0006595 | polyamine metabolic process | 8.745492e-4 |
GO:0072091 | regulation of stem cell proliferation | 8.933799e-4 |
GO:0048524 | positive regulation of viral reproduction | 9.220310e-4 |
GO:0048641 | regulation of skeletal muscle tissue development | 9.272643e-4 |
GO:0030520 | estrogen receptor signaling pathway | 9.638627e-4 |
GO:0002011 | morphogenesis of an epithelial sheet | 9.844801e-4 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.012056e-3 |
GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development | 1.025987e-3 |
GO:0006855 | drug transmembrane transport | 1.047263e-3 |
GO:0021915 | neural tube development | 1.059499e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 1.077821e-3 |
GO:0051349 | positive regulation of lyase activity | 1.092530e-3 |
GO:0007212 | dopamine receptor signaling pathway | 1.101767e-3 |
GO:0000959 | mitochondrial RNA metabolic process | 1.103717e-3 |
GO:0017145 | stem cell division | 1.115259e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.120313e-3 |
GO:0001941 | postsynaptic membrane organization | 1.120896e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.131507e-3 |
GO:0007189 | activation of adenylate cyclase activity by G-protein signaling pathway | 1.154581e-3 |
GO:0048690 | regulation of axon extension involved in regeneration | 1.178605e-3 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 1.178605e-3 |
GO:0010605 | negative regulation of macromolecule metabolic process | 1.220259e-3 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 1.221227e-3 |
GO:0070194 | synaptonemal complex disassembly | 1.221227e-3 |
GO:0001522 | pseudouridine synthesis | 1.221510e-3 |
GO:0072086 | specification of loop of Henle identity | 1.244525e-3 |
GO:0018350 | protein esterification | 1.244525e-3 |
GO:0044258 | intestinal lipid catabolic process | 1.244525e-3 |
GO:0072179 | nephric duct formation | 1.256397e-3 |
GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway | 1.280565e-3 |
GO:0015893 | drug transport | 1.306676e-3 |
GO:0006396 | RNA processing | 1.307358e-3 |
GO:2000772 | regulation of cellular senescence | 1.318883e-3 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.334025e-3 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 1.373947e-3 |
GO:0035364 | thymine transport | 1.373947e-3 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 1.373947e-3 |
GO:0035344 | hypoxanthine transport | 1.373947e-3 |
GO:0015854 | guanine transport | 1.373947e-3 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 1.373947e-3 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 1.373947e-3 |
GO:0021532 | neural tube patterning | 1.376727e-3 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 1.378561e-3 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 1.378561e-3 |
GO:0007371 | ventral midline determination | 1.378561e-3 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 1.378561e-3 |
GO:0060435 | bronchiole development | 1.404877e-3 |
GO:0021877 | forebrain neuron fate commitment | 1.425067e-3 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 1.426839e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 1.438579e-3 |
GO:0031507 | heterochromatin formation | 1.441757e-3 |
GO:0060480 | lung goblet cell differentiation | 1.445259e-3 |
GO:0003338 | metanephros morphogenesis | 1.501389e-3 |
GO:0045136 | development of secondary sexual characteristics | 1.504675e-3 |
GO:0032808 | lacrimal gland development | 1.519221e-3 |
GO:0061351 | neural precursor cell proliferation | 1.531549e-3 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 1.558015e-3 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 1.613186e-3 |
GO:0031591 | wybutosine biosynthetic process | 1.613186e-3 |
GO:0006844 | acyl carnitine transport | 1.613186e-3 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.659305e-3 |
GO:0040009 | regulation of growth rate | 1.660792e-3 |
GO:0021535 | cell migration in hindbrain | 1.678556e-3 |
GO:0072210 | metanephric nephron development | 1.693010e-3 |
GO:0048340 | paraxial mesoderm morphogenesis | 1.694162e-3 |
GO:0055021 | regulation of cardiac muscle tissue growth | 1.730475e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1.751801e-3 |
GO:0070173 | regulation of enamel mineralization | 1.771862e-3 |
GO:0048663 | neuron fate commitment | 1.794930e-3 |
GO:0009889 | regulation of biosynthetic process | 1.814696e-3 |
GO:0021510 | spinal cord development | 1.815679e-3 |
GO:0035117 | embryonic arm morphogenesis | 1.828564e-3 |
GO:0051660 | establishment of centrosome localization | 1.834310e-3 |
GO:0071335 | hair follicle cell proliferation | 1.834310e-3 |
GO:0032290 | peripheral nervous system myelin formation | 1.834310e-3 |
GO:0021540 | corpus callosum morphogenesis | 1.834310e-3 |
GO:0055117 | regulation of cardiac muscle contraction | 1.849815e-3 |
GO:0050435 | beta-amyloid metabolic process | 1.869743e-3 |
GO:0040015 | negative regulation of multicellular organism growth | 1.869743e-3 |
GO:0021759 | globus pallidus development | 1.901839e-3 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 1.939335e-3 |
GO:0045900 | negative regulation of translational elongation | 1.940997e-3 |
GO:0032066 | nucleolus to nucleoplasm transport | 1.940997e-3 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1.951124e-3 |
GO:0060282 | positive regulation of oocyte development | 1.958080e-3 |
GO:0003180 | aortic valve morphogenesis | 2.022022e-3 |
GO:0048562 | embryonic organ morphogenesis | 2.064511e-3 |
GO:0002076 | osteoblast development | 2.121276e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 2.153692e-3 |
GO:0030262 | apoptotic nuclear change | 2.166429e-3 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 2.169409e-3 |
GO:0048341 | paraxial mesoderm formation | 2.176188e-3 |
GO:0030423 | targeting of mRNA for destruction involved in RNA interference | 2.231720e-3 |
GO:0048754 | branching morphogenesis of a tube | 2.289983e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 2.307325e-3 |
GO:0040040 | thermosensory behavior | 2.331633e-3 |
GO:0032792 | negative regulation of CREB transcription factor activity | 2.371750e-3 |
GO:0071224 | cellular response to peptidoglycan | 2.382456e-3 |
GO:0021516 | dorsal spinal cord development | 2.422645e-3 |
GO:0034971 | histone H3-R17 methylation | 2.440168e-3 |
GO:0000088 | mitotic prophase | 2.440168e-3 |
GO:0050928 | negative regulation of positive chemotaxis | 2.504302e-3 |
GO:0070307 | lens fiber cell development | 2.510664e-3 |
GO:0003334 | keratinocyte development | 2.560696e-3 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 2.566534e-3 |
GO:0021905 | forebrain-midbrain boundary formation | 2.566534e-3 |
GO:0003322 | pancreatic A cell development | 2.566534e-3 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 2.566534e-3 |
GO:0048593 | camera-type eye morphogenesis | 2.598897e-3 |
GO:0003016 | respiratory system process | 2.612445e-3 |
GO:0016577 | histone demethylation | 2.687984e-3 |
GO:0060482 | lobar bronchus development | 2.695032e-3 |
GO:0003360 | brainstem development | 2.704469e-3 |
GO:0034699 | response to luteinizing hormone stimulus | 2.735757e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.735757e-3 |
GO:0070534 | protein K63-linked ubiquitination | 2.797080e-3 |
GO:0003382 | epithelial cell morphogenesis | 2.887013e-3 |
GO:0009954 | proximal/distal pattern formation | 2.912653e-3 |
GO:0006551 | leucine metabolic process | 2.947569e-3 |
GO:0006807 | nitrogen compound metabolic process | 2.956419e-3 |
GO:0090140 | regulation of mitochondrial fission | 2.958818e-3 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 2.958818e-3 |
GO:0002066 | columnar/cuboidal epithelial cell development | 2.988293e-3 |
GO:0032790 | ribosome disassembly | 3.005960e-3 |
GO:0090344 | negative regulation of cell aging | 3.035490e-3 |
GO:0035239 | tube morphogenesis | 3.057496e-3 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 3.074128e-3 |
GO:0006370 | mRNA capping | 3.114255e-3 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 3.128340e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 3.214479e-3 |
GO:0051447 | negative regulation of meiotic cell cycle | 3.233244e-3 |
GO:0002009 | morphogenesis of an epithelium | 3.300928e-3 |
GO:0043353 | enucleate erythrocyte differentiation | 3.316193e-3 |
GO:0051096 | positive regulation of helicase activity | 3.355032e-3 |
GO:0006401 | RNA catabolic process | 3.381826e-3 |
GO:0048285 | organelle fission | 3.416299e-3 |
GO:0071166 | ribonucleoprotein complex localization | 3.457395e-3 |
GO:0035356 | cellular triglyceride homeostasis | 3.457395e-3 |
GO:0072273 | metanephric nephron morphogenesis | 3.466069e-3 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 3.473271e-3 |
GO:0009067 | aspartate family amino acid biosynthetic process | 3.498230e-3 |
GO:0072006 | nephron development | 3.517833e-3 |
GO:0034616 | response to laminar fluid shear stress | 3.523912e-3 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 3.524961e-3 |
GO:0060046 | regulation of acrosome reaction | 3.603054e-3 |
GO:0009086 | methionine biosynthetic process | 3.697373e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 3.699437e-3 |
GO:0018872 | arsonoacetate metabolic process | 3.699437e-3 |
GO:0007113 | endomitotic cell cycle | 3.699437e-3 |
GO:0006425 | glutaminyl-tRNA aminoacylation | 3.699437e-3 |
GO:0046514 | ceramide catabolic process | 3.758113e-3 |
GO:0000097 | sulfur amino acid biosynthetic process | 3.767226e-3 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 3.784665e-3 |
GO:0072017 | distal tubule development | 3.805144e-3 |
GO:0030302 | deoxynucleotide transport | 3.865801e-3 |
GO:0002380 | immunoglobulin secretion involved in immune response | 3.865801e-3 |
GO:0072332 | signal transduction by p53 class mediator resulting in induction of apoptosis | 3.931983e-3 |
GO:0007140 | male meiosis | 3.935633e-3 |
GO:0001544 | initiation of primordial ovarian follicle growth | 3.979866e-3 |
GO:0007492 | endoderm development | 4.017839e-3 |
GO:0090281 | negative regulation of calcium ion import | 4.025788e-3 |
GO:0071584 | negative regulation of zinc ion import | 4.025788e-3 |
GO:0000073 | spindle pole body separation | 4.025788e-3 |
GO:0031627 | telomeric loop formation | 4.025788e-3 |
GO:0022904 | respiratory electron transport chain | 4.104260e-3 |
GO:0071167 | ribonucleoprotein complex import into nucleus | 4.122622e-3 |
GO:0051083 | 'de novo' cotranslational protein folding | 4.122622e-3 |
GO:0061303 | cornea development in camera-type eye | 4.176926e-3 |
GO:2000774 | positive regulation of cellular senescence | 4.235412e-3 |
GO:0035986 | senescence-associated heterochromatin focus formation | 4.235412e-3 |
GO:0042770 | signal transduction in response to DNA damage | 4.338866e-3 |
GO:0032239 | regulation of nucleobase-containing compound transport | 4.339611e-3 |
GO:0001763 | morphogenesis of a branching structure | 4.371999e-3 |
GO:0043113 | receptor clustering | 4.415695e-3 |
GO:2000736 | regulation of stem cell differentiation | 4.425547e-3 |
GO:0000710 | meiotic mismatch repair | 4.454218e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 4.454218e-3 |
GO:0009798 | axis specification | 4.473131e-3 |
GO:0060004 | reflex | 4.484597e-3 |
GO:0003002 | regionalization | 4.539177e-3 |
GO:0001501 | skeletal system development | 4.611149e-3 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 4.673296e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 4.673296e-3 |
GO:0015734 | taurine transport | 4.673296e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 4.673296e-3 |
GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation | 4.868593e-3 |
GO:0090303 | positive regulation of wound healing | 4.907989e-3 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 4.981478e-3 |
GO:0015884 | folic acid transport | 5.081816e-3 |
GO:0048701 | embryonic cranial skeleton morphogenesis | 5.106795e-3 |
GO:0034508 | centromere complex assembly | 5.119385e-3 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 5.213448e-3 |
GO:0031536 | positive regulation of exit from mitosis | 5.228166e-3 |
GO:0060534 | trachea cartilage development | 5.238368e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 5.244036e-3 |
GO:0046113 | nucleobase catabolic process | 5.337366e-3 |
GO:0061386 | closure of optic fissure | 5.376986e-3 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 5.376986e-3 |
GO:0019056 | modulation by virus of host transcription | 5.376986e-3 |
GO:0035332 | positive regulation of hippo signaling cascade | 5.376986e-3 |
GO:0048691 | positive regulation of axon extension involved in regeneration | 5.376986e-3 |
GO:0007067 | mitosis | 5.388488e-3 |
GO:0003206 | cardiac chamber morphogenesis | 5.401610e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 5.403422e-3 |
GO:2000696 | regulation of epithelial cell differentiation involved in kidney development | 5.498371e-3 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 5.522345e-3 |
GO:0022403 | cell cycle phase | 5.564629e-3 |
GO:0051642 | centrosome localization | 5.643141e-3 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 5.647023e-3 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 5.651690e-3 |
GO:0090004 | positive regulation of establishment of protein localization in plasma membrane | 5.742633e-3 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 5.762947e-3 |
GO:0090168 | Golgi reassembly | 5.762947e-3 |
GO:0021588 | cerebellum formation | 5.762947e-3 |
GO:2000002 | negative regulation of DNA damage checkpoint | 5.762947e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 5.762947e-3 |
GO:0014895 | smooth muscle hypertrophy | 5.762947e-3 |
GO:0021551 | central nervous system morphogenesis | 5.762947e-3 |
GO:0030641 | regulation of cellular pH | 5.865267e-3 |
GO:0060562 | epithelial tube morphogenesis | 5.865854e-3 |
GO:0060485 | mesenchyme development | 5.885687e-3 |
GO:2000210 | positive regulation of anoikis | 6.080248e-3 |
GO:2000685 | positive regulation of cellular response to X-ray | 6.080248e-3 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 6.080248e-3 |
GO:2001038 | regulation of cellular response to drug | 6.080248e-3 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 6.080248e-3 |
GO:0003131 | mesodermal-endodermal cell signaling | 6.080248e-3 |
GO:0031052 | chromosome breakage | 6.080248e-3 |
GO:0035978 | histone H2A-S139 phosphorylation | 6.080248e-3 |
GO:0051153 | regulation of striated muscle cell differentiation | 6.094021e-3 |
GO:0009892 | negative regulation of metabolic process | 6.175189e-3 |
GO:0006482 | protein demethylation | 6.196385e-3 |
GO:0008272 | sulfate transport | 6.231831e-3 |
GO:0010025 | wax biosynthetic process | 6.261006e-3 |
GO:0046607 | positive regulation of centrosome cycle | 6.261006e-3 |
GO:0009822 | alkaloid catabolic process | 6.261006e-3 |
GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | 6.287700e-3 |
GO:0035264 | multicellular organism growth | 6.401521e-3 |
GO:0055024 | regulation of cardiac muscle tissue development | 6.421901e-3 |
GO:0019087 | transformation of host cell by virus | 6.455242e-3 |
GO:0021879 | forebrain neuron differentiation | 6.493493e-3 |
GO:0060174 | limb bud formation | 6.500818e-3 |
GO:0065001 | specification of axis polarity | 6.518444e-3 |
GO:0045333 | cellular respiration | 6.612159e-3 |
GO:0045747 | positive regulation of Notch signaling pathway | 6.641805e-3 |
GO:0048149 | behavioral response to ethanol | 6.651907e-3 |
GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity | 6.651907e-3 |
GO:0072178 | nephric duct morphogenesis | 6.657626e-3 |
GO:0035026 | leading edge cell differentiation | 6.662197e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 6.662197e-3 |
GO:0000578 | embryonic axis specification | 6.691692e-3 |
GO:0022027 | interkinetic nuclear migration | 6.775919e-3 |
GO:0045604 | regulation of epidermal cell differentiation | 6.853447e-3 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 6.860057e-3 |
GO:0006552 | leucine catabolic process | 6.860057e-3 |
GO:0060675 | ureteric bud morphogenesis | 6.886517e-3 |
GO:0005984 | disaccharide metabolic process | 6.928712e-3 |
GO:0043393 | regulation of protein binding | 6.985345e-3 |
GO:0006390 | transcription from mitochondrial promoter | 7.058941e-3 |
GO:0042593 | glucose homeostasis | 7.186864e-3 |
GO:0060420 | regulation of heart growth | 7.236727e-3 |
GO:0003215 | cardiac right ventricle morphogenesis | 7.330579e-3 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 7.361472e-3 |
GO:0009880 | embryonic pattern specification | 7.489802e-3 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 7.535233e-3 |
GO:0010894 | negative regulation of steroid biosynthetic process | 7.554209e-3 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 7.726115e-3 |
GO:0006713 | glucocorticoid catabolic process | 7.726115e-3 |
GO:0032223 | negative regulation of synaptic transmission, cholinergic | 7.726115e-3 |
GO:0060644 | mammary gland epithelial cell differentiation | 7.729988e-3 |
GO:0000731 | DNA synthesis involved in DNA repair | 7.782837e-3 |
GO:2000036 | regulation of stem cell maintenance | 7.785086e-3 |
GO:0010822 | positive regulation of mitochondrion organization | 7.785086e-3 |
GO:0070715 | sodium-dependent organic cation transport | 7.786883e-3 |
GO:0052106 | quorum sensing involved in interaction with host | 7.786883e-3 |
GO:0060731 | positive regulation of intestinal epithelial structure maintenance | 7.786883e-3 |
GO:0006119 | oxidative phosphorylation | 8.022093e-3 |
GO:0048742 | regulation of skeletal muscle fiber development | 8.042771e-3 |
GO:0072331 | signal transduction by p53 class mediator | 8.079321e-3 |
GO:0060711 | labyrinthine layer development | 8.087007e-3 |
GO:0071895 | odontoblast differentiation | 8.161196e-3 |
GO:0035385 | Roundabout signaling pathway | 8.161196e-3 |
GO:0002052 | positive regulation of neuroblast proliferation | 8.234574e-3 |
GO:0006903 | vesicle targeting | 8.243086e-3 |
GO:0072236 | metanephric loop of Henle development | 8.263263e-3 |
GO:0060281 | regulation of oocyte development | 8.263263e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 8.362550e-3 |
GO:2000824 | negative regulation of androgen receptor activity | 8.384238e-3 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 8.384238e-3 |
GO:0072240 | metanephric DCT cell differentiation | 8.394620e-3 |
GO:0072227 | metanephric macula densa development | 8.394620e-3 |
GO:0048561 | establishment of organ orientation | 8.401431e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 8.401431e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0008635 | activation of caspase activity by cytochrome c | 5.349733e-9 |
GO:0007067 | mitosis | 7.802759e-9 |
GO:0000087 | M phase of mitotic cell cycle | 9.290048e-9 |
GO:0035305 | negative regulation of dephosphorylation | 2.548970e-8 |
GO:0048285 | organelle fission | 1.012029e-7 |
GO:0000278 | mitotic cell cycle | 1.466732e-7 |
GO:0022402 | cell cycle process | 4.345079e-7 |
GO:0006540 | glutamate decarboxylation to succinate | 6.471164e-7 |
GO:0035307 | positive regulation of protein dephosphorylation | 9.797550e-7 |
GO:0035304 | regulation of protein dephosphorylation | 1.067267e-6 |
GO:0035306 | positive regulation of dephosphorylation | 1.254053e-6 |
GO:0017158 | regulation of calcium ion-dependent exocytosis | 1.438147e-6 |
GO:0071169 | establishment of protein localization to chromatin | 1.924786e-6 |
GO:0006513 | protein monoubiquitination | 2.070558e-6 |
GO:0000279 | M phase | 2.684313e-6 |
GO:0045647 | negative regulation of erythrocyte differentiation | 3.001955e-6 |
GO:0035308 | negative regulation of protein dephosphorylation | 3.396598e-6 |
GO:0022403 | cell cycle phase | 4.068966e-6 |
GO:0034660 | ncRNA metabolic process | 1.062544e-5 |
GO:0060046 | regulation of acrosome reaction | 1.162798e-5 |
GO:0006268 | DNA unwinding involved in replication | 1.170770e-5 |
GO:0051204 | protein insertion into mitochondrial membrane | 1.184219e-5 |
GO:0071394 | cellular response to testosterone stimulus | 1.199402e-5 |
GO:0002352 | B cell negative selection | 1.199402e-5 |
GO:0046604 | positive regulation of mitotic centrosome separation | 1.261716e-5 |
GO:0061013 | regulation of mRNA catabolic process | 1.315594e-5 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 1.334296e-5 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 1.334296e-5 |
GO:0032119 | sequestering of zinc ion | 1.455620e-5 |
GO:0051238 | sequestering of metal ion | 1.469665e-5 |
GO:0033169 | histone H3-K9 demethylation | 1.594081e-5 |
GO:0090102 | cochlea development | 1.832828e-5 |
GO:0046929 | negative regulation of neurotransmitter secretion | 2.270722e-5 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 2.270722e-5 |
GO:0034441 | plasma lipoprotein particle oxidation | 2.270722e-5 |
GO:0046092 | deoxycytidine metabolic process | 2.373397e-5 |
GO:0070076 | histone lysine demethylation | 2.630099e-5 |
GO:0035329 | hippo signaling cascade | 2.678960e-5 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 2.905373e-5 |
GO:0060048 | cardiac muscle contraction | 2.996615e-5 |
GO:0060574 | intestinal epithelial cell maturation | 3.132049e-5 |
GO:0001510 | RNA methylation | 3.445326e-5 |
GO:0043117 | positive regulation of vascular permeability | 3.704846e-5 |
GO:0016458 | gene silencing | 3.975007e-5 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.005721e-5 |
GO:0030825 | positive regulation of cGMP metabolic process | 4.412600e-5 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 4.945101e-5 |
GO:0016070 | RNA metabolic process | 5.400184e-5 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 5.520345e-5 |
GO:0007006 | mitochondrial membrane organization | 6.330701e-5 |
GO:0010467 | gene expression | 6.696450e-5 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 6.738586e-5 |
GO:0032232 | negative regulation of actin filament bundle assembly | 7.066320e-5 |
GO:0031047 | gene silencing by RNA | 7.079089e-5 |
GO:0006590 | thyroid hormone generation | 7.124408e-5 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 7.369096e-5 |
GO:0046602 | regulation of mitotic centrosome separation | 8.129775e-5 |
GO:0016142 | O-glycoside catabolic process | 8.270275e-5 |
GO:0010498 | proteasomal protein catabolic process | 8.712064e-5 |
GO:0035461 | vitamin transmembrane transport | 9.114033e-5 |
GO:0042136 | neurotransmitter biosynthetic process | 1.012304e-4 |
GO:0046666 | retinal cell programmed cell death | 1.165082e-4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.254991e-4 |
GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 1.277426e-4 |
GO:0031536 | positive regulation of exit from mitosis | 1.351979e-4 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 1.417546e-4 |
GO:0032508 | DNA duplex unwinding | 1.439051e-4 |
GO:0070460 | thyroid-stimulating hormone secretion | 1.455330e-4 |
GO:0071359 | cellular response to dsRNA | 1.549603e-4 |
GO:0006396 | RNA processing | 1.629719e-4 |
GO:0071557 | histone H3-K27 demethylation | 1.660363e-4 |
GO:0035574 | histone H4-K20 demethylation | 1.660363e-4 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 1.829462e-4 |
GO:0001777 | T cell homeostatic proliferation | 1.829462e-4 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.912158e-4 |
GO:2000344 | positive regulation of acrosome reaction | 1.930504e-4 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.940482e-4 |
GO:0002674 | negative regulation of acute inflammatory response | 1.998856e-4 |
GO:0032392 | DNA geometric change | 2.223597e-4 |
GO:0032479 | regulation of type I interferon production | 2.317018e-4 |
GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 2.333823e-4 |
GO:0071360 | cellular response to exogenous dsRNA | 2.386394e-4 |
GO:0042268 | regulation of cytolysis | 2.449228e-4 |
GO:0016926 | protein desumoylation | 2.449228e-4 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 2.466667e-4 |
GO:0034332 | adherens junction organization | 2.548763e-4 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 2.579136e-4 |
GO:0007049 | cell cycle | 2.740959e-4 |
GO:0030823 | regulation of cGMP metabolic process | 2.787692e-4 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 2.889321e-4 |
GO:0043414 | macromolecule methylation | 2.938006e-4 |
GO:0051171 | regulation of nitrogen compound metabolic process | 2.942729e-4 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 3.050753e-4 |
GO:0032481 | positive regulation of type I interferon production | 3.183486e-4 |
GO:0035303 | regulation of dephosphorylation | 3.271332e-4 |
GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 3.276418e-4 |
GO:0016139 | glycoside catabolic process | 3.366317e-4 |
GO:0045713 | low-density lipoprotein particle receptor biosynthetic process | 3.366317e-4 |
GO:0045662 | negative regulation of myoblast differentiation | 3.404536e-4 |
GO:0010564 | regulation of cell cycle process | 3.504000e-4 |
GO:0006235 | dTTP biosynthetic process | 3.589307e-4 |
GO:0072197 | ureter morphogenesis | 3.593777e-4 |
GO:0070831 | basement membrane assembly | 3.695884e-4 |
GO:0006391 | transcription initiation from mitochondrial promoter | 3.695884e-4 |
GO:0018364 | peptidyl-glutamine methylation | 3.695884e-4 |
GO:0071872 | cellular response to epinephrine stimulus | 3.728997e-4 |
GO:0061014 | positive regulation of mRNA catabolic process | 4.109760e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 4.109760e-4 |
GO:0048227 | plasma membrane to endosome transport | 4.331307e-4 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 4.604672e-4 |
GO:0006044 | N-acetylglucosamine metabolic process | 4.609155e-4 |
GO:0070544 | histone H3-K36 demethylation | 4.613451e-4 |
GO:0006538 | glutamate catabolic process | 4.882722e-4 |
GO:0051974 | negative regulation of telomerase activity | 4.943151e-4 |
GO:0060013 | righting reflex | 5.393857e-4 |
GO:2000427 | positive regulation of apoptotic cell clearance | 5.420727e-4 |
GO:0080164 | regulation of nitric oxide metabolic process | 5.420727e-4 |
GO:0007057 | spindle assembly involved in female meiosis I | 5.420727e-4 |
GO:0000103 | sulfate assimilation | 5.653464e-4 |
GO:0035520 | monoubiquitinated protein deubiquitination | 5.821231e-4 |
GO:0010994 | free ubiquitin chain polymerization | 5.821231e-4 |
GO:0007525 | somatic muscle development | 6.295948e-4 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 6.404259e-4 |
GO:0051414 | response to cortisol stimulus | 7.215935e-4 |
GO:2000016 | negative regulation of determination of dorsal identity | 7.476168e-4 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 7.480333e-4 |
GO:0060336 | negative regulation of interferon-gamma-mediated signaling pathway | 7.480333e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 7.619295e-4 |
GO:0044249 | cellular biosynthetic process | 7.765180e-4 |
GO:0006108 | malate metabolic process | 7.949107e-4 |
GO:0060433 | bronchus development | 8.727321e-4 |
GO:0032967 | positive regulation of collagen biosynthetic process | 8.774547e-4 |
GO:0044253 | positive regulation of multicellular organismal metabolic process | 9.213513e-4 |
GO:0032006 | regulation of TOR signaling cascade | 9.255668e-4 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 9.412014e-4 |
GO:0051583 | dopamine uptake | 9.412014e-4 |
GO:0090304 | nucleic acid metabolic process | 9.510722e-4 |
GO:0010046 | response to mycotoxin | 9.566012e-4 |
GO:0006434 | seryl-tRNA aminoacylation | 9.566012e-4 |
GO:0034470 | ncRNA processing | 9.636750e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.008216e-3 |
GO:0051497 | negative regulation of stress fiber assembly | 1.055050e-3 |
GO:0006040 | amino sugar metabolic process | 1.126955e-3 |
GO:0003406 | retinal pigment epithelium development | 1.143262e-3 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 1.143262e-3 |
GO:0010390 | histone monoubiquitination | 1.148003e-3 |
GO:0016072 | rRNA metabolic process | 1.155239e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.162296e-3 |
GO:0045921 | positive regulation of exocytosis | 1.174228e-3 |
GO:0072659 | protein localization in plasma membrane | 1.175171e-3 |
GO:0060480 | lung goblet cell differentiation | 1.188587e-3 |
GO:0060576 | intestinal epithelial cell development | 1.192112e-3 |
GO:0032331 | negative regulation of chondrocyte differentiation | 1.216675e-3 |
GO:0001502 | cartilage condensation | 1.227123e-3 |
GO:0006172 | ADP biosynthetic process | 1.250731e-3 |
GO:0016140 | O-glycoside metabolic process | 1.324029e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 1.324029e-3 |
GO:0009236 | cobalamin biosynthetic process | 1.324029e-3 |
GO:0002638 | negative regulation of immunoglobulin production | 1.324029e-3 |
GO:0001811 | negative regulation of type I hypersensitivity | 1.324029e-3 |
GO:0006863 | purine base transport | 1.325108e-3 |
GO:0007256 | activation of JNKK activity | 1.350491e-3 |
GO:0051301 | cell division | 1.438753e-3 |
GO:0072661 | protein targeting to plasma membrane | 1.504758e-3 |
GO:0032799 | low-density lipoprotein receptor particle metabolic process | 1.504758e-3 |
GO:0016577 | histone demethylation | 1.504761e-3 |
GO:0007096 | regulation of exit from mitosis | 1.516843e-3 |
GO:0045919 | positive regulation of cytolysis | 1.517006e-3 |
GO:0009597 | detection of virus | 1.517006e-3 |
GO:0010629 | negative regulation of gene expression | 1.640963e-3 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 1.658448e-3 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 1.690773e-3 |
GO:0060005 | vestibular reflex | 1.690773e-3 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 1.693521e-3 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 1.739551e-3 |
GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway | 1.773606e-3 |
GO:0071168 | protein localization to chromatin | 1.778142e-3 |
GO:0007529 | establishment of synaptic specificity at neuromuscular junction | 1.785630e-3 |
GO:0051726 | regulation of cell cycle | 1.836545e-3 |
GO:0060047 | heart contraction | 1.840509e-3 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 1.858094e-3 |
GO:0051291 | protein heterooligomerization | 1.925122e-3 |
GO:0044246 | regulation of multicellular organismal metabolic process | 1.937784e-3 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 1.945881e-3 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 1.945881e-3 |
GO:0061360 | optic chiasma development | 1.945881e-3 |
GO:2000597 | positive regulation of optic nerve formation | 1.945881e-3 |
GO:0035799 | ureter maturation | 1.945881e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 1.945881e-3 |
GO:0018343 | protein farnesylation | 1.945881e-3 |
GO:0021633 | optic nerve structural organization | 1.945881e-3 |
GO:0021650 | vestibulocochlear nerve formation | 1.945881e-3 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 1.945881e-3 |
GO:0035786 | protein complex oligomerization | 1.945881e-3 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 2.007892e-3 |
GO:0050691 | regulation of defense response to virus by host | 2.040079e-3 |
GO:0060686 | negative regulation of prostatic bud formation | 2.079122e-3 |
GO:0032965 | regulation of collagen biosynthetic process | 2.091063e-3 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.117252e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 2.119771e-3 |
GO:0006482 | protein demethylation | 2.196554e-3 |
GO:0033327 | Leydig cell differentiation | 2.330079e-3 |
GO:0000320 | re-entry into mitotic cell cycle | 2.330214e-3 |
GO:0072221 | metanephric distal convoluted tubule development | 2.336520e-3 |
GO:0006657 | CDP-choline pathway | 2.336520e-3 |
GO:0048147 | negative regulation of fibroblast proliferation | 2.400775e-3 |
GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway | 2.400775e-3 |
GO:0090234 | regulation of kinetochore assembly | 2.439634e-3 |
GO:0090169 | regulation of spindle assembly | 2.439634e-3 |
GO:0060012 | synaptic transmission, glycinergic | 2.443210e-3 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.443210e-3 |
GO:0042938 | dipeptide transport | 2.443210e-3 |
GO:0032239 | regulation of nucleobase-containing compound transport | 2.473412e-3 |
GO:0060992 | response to fungicide | 2.508577e-3 |
GO:0009058 | biosynthetic process | 2.527000e-3 |
GO:0008054 | cyclin catabolic process | 2.539889e-3 |
GO:0006390 | transcription from mitochondrial promoter | 2.565348e-3 |
GO:0002062 | chondrocyte differentiation | 2.615073e-3 |
GO:0044260 | cellular macromolecule metabolic process | 2.662334e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 2.751991e-3 |
GO:0072202 | cell differentiation involved in metanephros development | 2.779292e-3 |
GO:0060412 | ventricular septum morphogenesis | 2.784337e-3 |
GO:0042254 | ribosome biogenesis | 2.808217e-3 |
GO:0006997 | nucleus organization | 2.846387e-3 |
GO:0051972 | regulation of telomerase activity | 2.868566e-3 |
GO:0016068 | type I hypersensitivity | 2.906696e-3 |
GO:0071934 | thiamine transmembrane transport | 2.906696e-3 |
GO:0010070 | zygote asymmetric cell division | 2.906696e-3 |
GO:0010966 | regulation of phosphate transport | 2.906696e-3 |
GO:0002430 | complement receptor mediated signaling pathway | 2.906696e-3 |
GO:0006261 | DNA-dependent DNA replication | 2.977805e-3 |
GO:0051382 | kinetochore assembly | 3.036887e-3 |
GO:0050928 | negative regulation of positive chemotaxis | 3.085649e-3 |
GO:0042231 | interleukin-13 biosynthetic process | 3.085649e-3 |
GO:2000256 | positive regulation of male germ cell proliferation | 3.085649e-3 |
GO:0006285 | base-excision repair, AP site formation | 3.085649e-3 |
GO:0002462 | tolerance induction to nonself antigen | 3.085649e-3 |
GO:0010725 | regulation of primitive erythrocyte differentiation | 3.085649e-3 |
GO:0019428 | allantoin biosynthetic process | 3.085649e-3 |
GO:0000186 | activation of MAPKK activity | 3.180391e-3 |
GO:0015747 | urate transport | 3.227063e-3 |
GO:0042308 | negative regulation of protein import into nucleus | 3.307631e-3 |
GO:0051318 | G1 phase | 3.317748e-3 |
GO:0051383 | kinetochore organization | 3.338877e-3 |
GO:0006851 | mitochondrial calcium ion transport | 3.338877e-3 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.356779e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 3.391166e-3 |
GO:0050849 | negative regulation of calcium-mediated signaling | 3.427601e-3 |
GO:0046847 | filopodium assembly | 3.498887e-3 |
GO:0001778 | plasma membrane repair | 3.525850e-3 |
GO:0035364 | thymine transport | 3.552829e-3 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 3.552829e-3 |
GO:0035344 | hypoxanthine transport | 3.552829e-3 |
GO:0015853 | adenine transport | 3.552829e-3 |
GO:0006348 | chromatin silencing at telomere | 3.552829e-3 |
GO:0015854 | guanine transport | 3.552829e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 3.566756e-3 |
GO:0021978 | telencephalon regionalization | 3.614668e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.719948e-3 |
GO:0010159 | specification of organ position | 3.719948e-3 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 3.720579e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 3.721335e-3 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 3.817184e-3 |
GO:0051252 | regulation of RNA metabolic process | 3.897438e-3 |
GO:0030421 | defecation | 3.980830e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 3.980830e-3 |
GO:0006526 | arginine biosynthetic process | 3.980830e-3 |
GO:0016574 | histone ubiquitination | 4.070186e-3 |
GO:0008209 | androgen metabolic process | 4.142804e-3 |
GO:0070979 | protein K11-linked ubiquitination | 4.158012e-3 |
GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 4.237766e-3 |
GO:0043968 | histone H2A acetylation | 4.314183e-3 |
GO:0032423 | regulation of mismatch repair | 4.475058e-3 |
GO:0048050 | post-embryonic eye morphogenesis | 4.522761e-3 |
GO:0060457 | negative regulation of digestive system process | 4.549822e-3 |
GO:0002575 | basophil chemotaxis | 4.549822e-3 |
GO:0060439 | trachea morphogenesis | 4.590759e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.601883e-3 |
GO:0071549 | cellular response to dexamethasone stimulus | 4.610773e-3 |
GO:0035518 | histone H2A monoubiquitination | 4.680542e-3 |
GO:0072240 | metanephric DCT cell differentiation | 4.708113e-3 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 4.708113e-3 |
GO:0072227 | metanephric macula densa development | 4.708113e-3 |
GO:0009065 | glutamine family amino acid catabolic process | 4.762400e-3 |
GO:0015851 | nucleobase transport | 4.819635e-3 |
GO:0042428 | serotonin metabolic process | 4.834638e-3 |
GO:2000736 | regulation of stem cell differentiation | 4.916467e-3 |
GO:0043457 | regulation of cellular respiration | 5.003185e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 5.041391e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 5.065776e-3 |
GO:0046607 | positive regulation of centrosome cycle | 5.065776e-3 |
GO:0046902 | regulation of mitochondrial membrane permeability | 5.224135e-3 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5.279005e-3 |
GO:0000959 | mitochondrial RNA metabolic process | 5.473593e-3 |
GO:0060435 | bronchiole development | 5.486873e-3 |
GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 5.490807e-3 |
GO:0006807 | nitrogen compound metabolic process | 5.727439e-3 |
GO:0072179 | nephric duct formation | 5.739085e-3 |
GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 5.824705e-3 |
GO:0007264 | small GTPase mediated signal transduction | 5.836592e-3 |
GO:0006919 | activation of caspase activity | 5.860901e-3 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 5.922754e-3 |
GO:0050685 | positive regulation of mRNA processing | 5.965532e-3 |
GO:0046108 | uridine metabolic process | 6.071369e-3 |
GO:0035611 | protein branching point deglutamylation | 6.071369e-3 |
GO:0021897 | forebrain astrocyte development | 6.071369e-3 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 6.152574e-3 |
GO:0010312 | detoxification of zinc ion | 6.152574e-3 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.203325e-3 |
GO:0017157 | regulation of exocytosis | 6.233204e-3 |
GO:0046293 | formaldehyde biosynthetic process | 6.272396e-3 |
GO:0048773 | erythrophore differentiation | 6.272396e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 6.272396e-3 |
GO:0034021 | response to silicon dioxide | 6.272396e-3 |
GO:0001315 | age-dependent response to reactive oxygen species | 6.272396e-3 |
GO:0003069 | vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure | 6.272396e-3 |
GO:0043252 | sodium-independent organic anion transport | 6.272396e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 6.319221e-3 |
GO:0033578 | protein glycosylation in Golgi | 6.335875e-3 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 6.335875e-3 |
GO:0001757 | somite specification | 6.335875e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 6.339063e-3 |
GO:0006364 | rRNA processing | 6.459675e-3 |
GO:0006351 | transcription, DNA-dependent | 6.494960e-3 |
GO:0006105 | succinate metabolic process | 6.523360e-3 |
GO:2000064 | regulation of cortisol biosynthetic process | 6.579866e-3 |
GO:0072076 | nephrogenic mesenchyme development | 6.579866e-3 |
GO:0046831 | regulation of RNA export from nucleus | 6.579866e-3 |
GO:0070171 | negative regulation of tooth mineralization | 6.579866e-3 |
GO:0043932 | ossification involved in bone remodeling | 6.584439e-3 |
GO:0009235 | cobalamin metabolic process | 6.584439e-3 |
GO:0007262 | STAT protein import into nucleus | 6.623981e-3 |
GO:0006983 | ER overload response | 6.903581e-3 |
GO:0003015 | heart process | 6.923312e-3 |
GO:0009451 | RNA modification | 6.984291e-3 |
GO:0010452 | histone H3-K36 methylation | 6.993411e-3 |
GO:0035993 | deltoid tuberosity development | 7.011210e-3 |
GO:0016075 | rRNA catabolic process | 7.011210e-3 |
GO:0006213 | pyrimidine nucleoside metabolic process | 7.190204e-3 |
GO:0051589 | negative regulation of neurotransmitter transport | 7.257953e-3 |
GO:0060390 | regulation of SMAD protein import into nucleus | 7.317628e-3 |
GO:0072074 | kidney mesenchyme development | 7.325284e-3 |
GO:0032774 | RNA biosynthetic process | 7.384305e-3 |
GO:0003073 | regulation of systemic arterial blood pressure | 7.514172e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 7.529226e-3 |
GO:0090103 | cochlea morphogenesis | 7.531047e-3 |
GO:0032008 | positive regulation of TOR signaling cascade | 7.536495e-3 |
GO:0006354 | transcription elongation, DNA-dependent | 7.576607e-3 |
GO:0046514 | ceramide catabolic process | 7.660613e-3 |
GO:0032648 | regulation of interferon-beta production | 7.690616e-3 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.709037e-3 |
GO:0045684 | positive regulation of epidermis development | 7.734974e-3 |
GO:2000036 | regulation of stem cell maintenance | 7.734974e-3 |
GO:0045646 | regulation of erythrocyte differentiation | 7.764939e-3 |
GO:0031326 | regulation of cellular biosynthetic process | 7.985120e-3 |
GO:2000242 | negative regulation of reproductive process | 8.014064e-3 |
GO:0030433 | ER-associated protein catabolic process | 8.139040e-3 |
GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development | 8.202384e-3 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 8.202384e-3 |
GO:0051660 | establishment of centrosome localization | 8.202384e-3 |
GO:0021540 | corpus callosum morphogenesis | 8.202384e-3 |
GO:0009409 | response to cold | 8.254647e-3 |
GO:0043330 | response to exogenous dsRNA | 8.263678e-3 |
GO:0048593 | camera-type eye morphogenesis | 8.311894e-3 |
GO:0010922 | positive regulation of phosphatase activity | 8.477193e-3 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 8.497949e-3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 8.563088e-3 |
GO:0010952 | positive regulation of peptidase activity | 8.721250e-3 |
GO:0061037 | negative regulation of cartilage development | 8.857671e-3 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 8.905491e-3 |
GO:0002358 | B cell homeostatic proliferation | 8.915891e-3 |
GO:0001986 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure | 8.915891e-3 |
GO:0007144 | female meiosis I | 9.097259e-3 |
GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 9.168540e-3 |
GO:0030970 | retrograde protein transport, ER to cytosol | 9.226561e-3 |
GO:0021758 | putamen development | 9.226561e-3 |
GO:0021757 | caudate nucleus development | 9.226561e-3 |
GO:0009059 | macromolecule biosynthetic process | 9.245192e-3 |
GO:0030035 | microspike assembly | 9.326299e-3 |
GO:0019933 | cAMP-mediated signaling | 9.584322e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 9.591054e-3 |
GO:0032387 | negative regulation of intracellular transport | 9.648518e-3 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 9.774037e-3 |
GO:0032025 | response to cobalt ion | 9.895583e-3 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 1.005628e-2 |
GO:0051457 | maintenance of protein location in nucleus | 1.016583e-2 |
GO:0071479 | cellular response to ionizing radiation | 1.019040e-2 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.036722e-2 |
GO:0043280 | positive regulation of caspase activity | 1.036803e-2 |
GO:0009452 | RNA capping | 1.048225e-2 |
GO:0006941 | striated muscle contraction | 1.050209e-2 |
GO:0001504 | neurotransmitter uptake | 1.050929e-2 |
GO:0006702 | androgen biosynthetic process | 1.056301e-2 |
GO:2000065 | negative regulation of cortisol biosynthetic process | 1.062573e-2 |
GO:0009088 | threonine biosynthetic process | 1.062573e-2 |
GO:0051610 | serotonin uptake | 1.062573e-2 |
GO:0032348 | negative regulation of aldosterone biosynthetic process | 1.062573e-2 |
GO:0045023 | G0 to G1 transition | 1.062573e-2 |
GO:0010107 | potassium ion import | 1.086676e-2 |
GO:0010950 | positive regulation of endopeptidase activity | 1.104219e-2 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 1.133554e-2 |
GO:0001841 | neural tube formation | 1.162885e-2 |
GO:0003166 | bundle of His development | 1.166556e-2 |
GO:0007097 | nuclear migration | 1.179131e-2 |
GO:0033683 | nucleotide-excision repair, DNA incision | 1.182146e-2 |
GO:0016081 | synaptic vesicle docking involved in exocytosis | 1.182146e-2 |
GO:0033522 | histone H2A ubiquitination | 1.185033e-2 |
GO:0032353 | negative regulation of hormone biosynthetic process | 1.186655e-2 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 1.186655e-2 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 1.196589e-2 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 1.196830e-2 |
GO:0003281 | ventricular septum development | 1.216944e-2 |
GO:0060685 | regulation of prostatic bud formation | 1.251225e-2 |
GO:0046103 | inosine biosynthetic process | 1.252176e-2 |
GO:0006154 | adenosine catabolic process | 1.252176e-2 |
GO:2000009 | negative regulation of protein localization at cell surface | 1.258510e-2 |
GO:0007207 | activation of phospholipase C activity by muscarinic acetylcholine receptor signaling pathway | 1.258510e-2 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 1.259095e-2 |
GO:0009299 | mRNA transcription | 1.259095e-2 |
GO:0090224 | regulation of spindle organization | 1.265860e-2 |
GO:0034651 | cortisol biosynthetic process | 1.287022e-2 |
GO:0019064 | viral envelope fusion with host membrane | 1.287022e-2 |
GO:0035865 | cellular response to potassium ion | 1.287022e-2 |
GO:0046814 | virion attachment, binding of host cell surface coreceptor | 1.287022e-2 |
GO:0015887 | pantothenate transmembrane transport | 1.287022e-2 |
GO:0006666 | 3-keto-sphinganine metabolic process | 1.287022e-2 |
GO:0015878 | biotin transport | 1.287022e-2 |
GO:0018206 | peptidyl-methionine modification | 1.295386e-2 |
GO:0006565 | L-serine catabolic process | 1.295386e-2 |
GO:0007569 | cell aging | 1.300679e-2 |
GO:0071285 | cellular response to lithium ion | 1.302608e-2 |
GO:0002063 | chondrocyte development | 1.345268e-2 |
GO:0051798 | positive regulation of hair follicle development | 1.366307e-2 |
GO:0006744 | ubiquinone biosynthetic process | 1.368107e-2 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 1.368866e-2 |
GO:0033523 | histone H2B ubiquitination | 1.375072e-2 |
GO:0006241 | CTP biosynthetic process | 1.376240e-2 |
GO:0071257 | cellular response to electrical stimulus | 1.376240e-2 |
GO:0009435 | NAD biosynthetic process | 1.376240e-2 |
GO:0042276 | error-prone translesion synthesis | 1.389095e-2 |
GO:0032011 | ARF protein signal transduction | 1.389095e-2 |
GO:0038007 | netrin-activated signaling pathway | 1.389095e-2 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 1.413294e-2 |
GO:0000075 | cell cycle checkpoint | 1.413294e-2 |
GO:0008210 | estrogen metabolic process | 1.437513e-2 |
GO:0007076 | mitotic chromosome condensation | 1.447044e-2 |
GO:0072162 | metanephric mesenchymal cell differentiation | 1.452840e-2 |
GO:0071711 | basement membrane organization | 1.452840e-2 |
GO:0031077 | post-embryonic camera-type eye development | 1.470195e-2 |
GO:0000183 | chromatin silencing at rDNA | 1.482141e-2 |
GO:0040001 | establishment of mitotic spindle localization | 1.490329e-2 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 1.516898e-2 |
GO:0010447 | response to acidity | 1.516898e-2 |
GO:0018022 | peptidyl-lysine methylation | 1.536843e-2 |
GO:0046677 | response to antibiotic | 1.547332e-2 |
GO:0045661 | regulation of myoblast differentiation | 1.548944e-2 |
GO:0006220 | pyrimidine nucleotide metabolic process | 1.550380e-2 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 1.556233e-2 |
GO:0034767 | positive regulation of ion transmembrane transport | 1.559605e-2 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 1.559605e-2 |
GO:0035117 | embryonic arm morphogenesis | 1.584079e-2 |
GO:0006379 | mRNA cleavage | 1.595592e-2 |
GO:0071407 | cellular response to organic cyclic compound | 1.608724e-2 |
GO:0031323 | regulation of cellular metabolic process | 1.646615e-2 |
GO:0090002 | establishment of protein localization in plasma membrane | 1.665561e-2 |
GO:0002230 | positive regulation of defense response to virus by host | 1.665561e-2 |
GO:0006419 | alanyl-tRNA aminoacylation | 1.677261e-2 |
GO:0046184 | aldehyde biosynthetic process | 1.677261e-2 |
GO:0061084 | negative regulation of protein refolding | 1.677261e-2 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.677261e-2 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.677261e-2 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 1.677261e-2 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 1.677261e-2 |
GO:0051148 | negative regulation of muscle cell differentiation | 1.682778e-2 |
GO:0070727 | cellular macromolecule localization | 1.684452e-2 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 1.689593e-2 |
GO:0050872 | white fat cell differentiation | 1.691501e-2 |
GO:0043331 | response to dsRNA | 1.705575e-2 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.705826e-2 |
GO:0071585 | detoxification of cadmium ion | 1.705826e-2 |
GO:0000053 | argininosuccinate metabolic process | 1.705826e-2 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 1.705826e-2 |
GO:0045836 | positive regulation of meiosis | 1.717121e-2 |
GO:0030866 | cortical actin cytoskeleton organization | 1.745322e-2 |
GO:0060931 | sinoatrial node cell development | 1.748970e-2 |
GO:0003167 | atrioventricular bundle cell differentiation | 1.748970e-2 |
GO:0072233 | metanephric thick ascending limb development | 1.750223e-2 |
GO:0072218 | metanephric ascending thin limb development | 1.750223e-2 |
GO:0060014 | granulosa cell differentiation | 1.750223e-2 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 1.750223e-2 |
GO:0018026 | peptidyl-lysine monomethylation | 1.755289e-2 |
GO:0002066 | columnar/cuboidal epithelial cell development | 1.755289e-2 |
GO:0008015 | blood circulation | 1.762187e-2 |
GO:0034613 | cellular protein localization | 1.762784e-2 |
GO:0071897 | DNA biosynthetic process | 1.774969e-2 |
GO:0090009 | primitive streak formation | 1.782412e-2 |
GO:0072537 | fibroblast activation | 1.785622e-2 |
GO:0032608 | interferon-beta production | 1.785622e-2 |
GO:0031109 | microtubule polymerization or depolymerization | 1.789570e-2 |
GO:0070936 | protein K48-linked ubiquitination | 1.794458e-2 |